<SEC-DOCUMENT>0001062993-23-021010.txt : 20231116
<SEC-HEADER>0001062993-23-021010.hdr.sgml : 20231116
<ACCEPTANCE-DATETIME>20231116171307
ACCESSION NUMBER:		0001062993-23-021010
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20231109
FILED AS OF DATE:		20231116
DATE AS OF CHANGE:		20231116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ImmunoPrecise Antibodies Ltd.
		CENTRAL INDEX KEY:			0001715925
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39530
		FILM NUMBER:		231415508

	BUSINESS ADDRESS:	
		STREET 1:		880 - 580 HORNBY STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C3B6
		BUSINESS PHONE:		6048060626

	MAIL ADDRESS:	
		STREET 1:		880 - 580 HORNBY STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C3B6
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>

<head>
    <title>ImmunoPrecise Antibodies Ltd.: Form 6-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><font style="font-size: 18pt;"><b>UNITED STATES</b></font><br><font style="font-size: 18pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></font><br>Washington, D.C. 20549<br><br><font style="font-size: 18pt;"><b>Form 6-K</b></font><br><br><b>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</b><br><b>UNDER THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: center;">For the month of <u><b>November, 2023</b></u>.</p>
    <p style="margin-bottom: 0pt; text-align: center;">Commission File Number: <font style="background-color: #ffffff;"><b>001-39530</b></font></p>
    <p style="margin-top: 0pt; text-align: center;"><br><br><u><b><font style="font-size: 18pt;">ImmunoPrecise Antibodies Ltd.</font></b></u><br>(Exact Name of Registrant as Specified in Charter)<br><br><font style="background-color: #ffffff;"><b>3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8</b></font><br>(Address of principal executive offices)</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</p>
    <p style="margin-top: 0pt; text-align: justify;">Form 20-F&#160; &#9633;&#160; Form 40-F &#8864;</p>
    <p style="text-align: center;"><b>INCORPORATION BY REFERENCE</b></p>
    <p style="text-align: justify;">Exhibit 99.1 of this Form 6-K is incorporated by reference into the Registrant's <a href="http://www.sec.gov/Archives/edgar/data/1715925/000106299323014797/formf3.htm"><u>Registration Statement on Form F-3 (File No. 333-273197)</u></a> and <a href="http://www.sec.gov/Archives/edgar/data/1715925/000119312521180096/d11553ds8.htm"><u>Registration Statement on Form S-8 (File No. 333-256730)</u></a>.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: center;"><b>SIGNATURE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 5%;">&#160;</td>
            <td style="width: 45%;">&#160;</td>
            <td colspan="2"><b>IMMUNOPRECISE ANTIBODIES LTD.</b></td>
        </tr>
        <tr>
            <td style="width: 5%;">&#160;</td>
            <td style="width: 45%;">&#160;</td>
            <td style="width: 5%;">&#160;</td>
            <td style="width: 45%;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%;">Date:</td>
            <td style="width: 45%;">November 16, 2023</td>
            <td style="width: 5%; border-bottom: 0.75pt solid #000000;">By:</td>
            <td style="width: 45%; border-bottom: 0.75pt solid #000000;"><i>/s/ Kristin Taylor<br></i></td>
        </tr>
        <tr>
            <td style="width: 5%;">&#160;</td>
            <td style="width: 45%;">&#160;</td>
            <td style="width: 5%;">Name:</td>
            <td style="width: 45%;">Kristin Taylor</td>
        </tr>
        <tr>
            <td style="width: 5%;">&#160;</td>
            <td style="width: 45%;">&#160;</td>
            <td style="width: 5%;">Title:</td>
            <td style="width: 45%;">Chief Financial Officer</td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><u><b>EXHIBIT INDEX</b></u></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-bottom: 0pt; background-color: #eeeeee;">
                <p><a href="exhibit99-1.htm">99.1</a></p>
            </td>
            <td style="margin-bottom: 0pt; background-color: #eeeeee;">
                <p><a href="exhibit99-1.htm">Report of Voting Results dated November 16, 2023</a></p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>ImmunoPrecise Antibodies Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center; margin-bottom: 0pt;"><b>Report of Voting Results</b></p>
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><b>Submitted Pursuant to</b></p>
    <p style="text-align: center; margin-top: 0pt;"><b>Section 11.3 of National Instrument 51-102 - </b><i><b>Continuous Disclosure Obligations</b></i></p>
    <p style="text-indent: 36pt; text-align: justify;">In accordance with Section 11.3 of National Instrument 51-102 - <i>Continuous Disclosure Obligations</i>, this report describes the matters voted upon and the outcome of the votes at the annual general meeting of shareholders of ImmunoPrecise Antibodies Ltd. (the "<b>Corporation</b>") held on November 9, 2023, via live webcast (the "<b>Meeting</b>"). Each of the matters is described in greater detail in the Corporation's management information circular dated October 16, 2023 (the "<b>Circular</b>").</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(a)<font style="width: 24.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The number of directors was set at five. The following are the voting results on this matter:</p>
    <div style="margin-left: 15pt;">
        <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #f2f2f2;">
                    <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #f2f2f2; white-space: nowrap;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><b>FOR</b></p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #f2f2f2; white-space: nowrap;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><b>% FOR</b></p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #f2f2f2; white-space: nowrap;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><b>AGAINST</b></p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #f2f2f2; white-space: nowrap;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><b>% AGAINST</b></p>
                </td>
            </tr>
            <tr>
                <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"><b>Number of Directors</b></p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;">8,516,846</p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;">93.29%</p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;">612,909</p>
                </td>
                <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;">6.71%</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(b)<font style="width: 24.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>In the Circular, management of the Corporation proposed five nominees for election as directors of the Corporation for the ensuing year or until their successors are duly elected or appointed. All five nominees were elected. The following are the voting results on this matter:</p>
    <div style="margin-left: 15pt;">
        <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="">
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #f1f1f1;">&#160;</td>
                <td style="width: 10%; vertical-align: middle; background-color: #f1f1f1; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b>FOR</b></td>
                <td style="width: 10%; vertical-align: middle; background-color: #f1f1f1; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b>% FOR</b></td>
                <td style="vertical-align: middle; background-color: #f1f1f1; width: 10%; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b>WITHHELD&#160; <br></b></td>
                <td style="vertical-align: middle; background-color: #f1f1f1; width: 10%; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b> % WITHHELD</b></td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff;"><b>Jennifer L. Bath</b></td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">6,985,276</td>
                <td style="width: 10%; vertical-align: middle; text-align: center; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">94.46%</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">409,710</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">5.54%</td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt;"><b>Chris Buyse</b></td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt;">7,325,144</td>
                <td style="width: 10%; vertical-align: middle; text-align: center; padding-left: 5.4pt; padding-right: 5.4pt;">99.06%</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt;">69,842</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt;">0.94%</td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff;"><b>Mitch Levine</b></td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">7,324,705</td>
                <td style="width: 10%; vertical-align: middle; text-align: center; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">99.05%</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">70,281</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">0.95%</td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt;"><b>Barry A. Springer</b></td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt;">7,324,876</td>
                <td style="width: 10%; vertical-align: middle; text-align: center; padding-left: 5.4pt; padding-right: 5.4pt;">99.05%</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt;">70,110</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt;">0.95%</td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff;"><b>Dirk Witters</b></td>
                <td style="width: 10%; vertical-align: top; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">7,335,209</td>
                <td style="width: 10%; vertical-align: top; text-align: center; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">99.19%</td>
                <td style="width: 10%; vertical-align: top; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">59,777</td>
                <td style="width: 10%; vertical-align: top; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">0.81%</td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">(c)<font style="width: 25.17pt; text-indent: 0pt; display: inline-block;">&#160;</font>Grant Thornton LLP was reappointed as the Corporation's auditors and the directors were authorized to fix the remuneration to be paid to the auditors. The following are the voting results on this matter:</p>
    <div style="margin-left: 15pt;">
        <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="">
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #f1f1f1;">&#160;</td>
                <td style="width: 10%; vertical-align: middle; background-color: #f1f1f1; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b>FOR</b></td>
                <td style="width: 10%; vertical-align: middle; background-color: #f1f1f1; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b>% FOR</b></td>
                <td style="vertical-align: middle; background-color: #f1f1f1; width: 10%; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b>WITHHELD&#160; <br></b></td>
                <td style="vertical-align: middle; background-color: #f1f1f1; width: 10%; text-align: center; white-space: nowrap; padding-left: 5.4pt; padding-right: 5.4pt;"><b> % WITHHELD</b></td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff;"><b>Reappointment of Auditors</b></td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">8,974,183&#160;</td>
                <td style="width: 10%; vertical-align: middle; text-align: center; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">98.30%</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">155,573</td>
                <td style="width: 10%; vertical-align: middle; text-align: right; padding-left: 5.4pt; padding-right: 5.4pt; background-color: #e6efff;">1.70%</td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">Dated this 16<sup>th</sup> day of November 2023.</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td colspan="2"><b>IMMUNOPRECISE ANTIBODIES LTD.</b></td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td style="width: 5%;">&#160;</td>
            <td>&#160;</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td><b>By:</b></td>
            <td><u><i><b>(signed) </b></i></u><b>Kristin Taylor</b></td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td><b>Name: Kristin Taylor</b></td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>&#160;</td>
            <td><b>Title: Chief Financial Officer</b></td>
        </tr>
    </table>
    <br>
    <div id="footer_page_1">
        <p style="text-align: right;">1</p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
